Complex PUO Analysis — 30-year-old Female

CT Abdomen/Pelvis — Key Findings (Report Summary)

• Large multiloculated complex cystic pelvic mass ~16.5 × 13.4 × 18 cm — bilateral iliac fossa extension, variably enhancing solid component, focal wall nodularity in left posterolateral aspect, bilateral ovaries not separately visualized
• Hepatomegaly (~17 cm)
• Mild right hydroureteronephrosis (mass effect)
• Mild ascites
• Retroperitoneal lymphadenopathy — elongated nodes up to ~1.4 cm
• Multiple sclerotic + lytic foci in mid/lower thoracic and lumbar vertebrae — ?significance
• Focal abutment on rectum
• Uterus displaced rightward

Diagnostic Framework — Two Parallel Pathologies

Diagnosis 1: Scrub Typhus (Rickettsial Infection)

• OXK (Weil-Felix) titre ≥ 1:320 — strongly positive (diagnostic threshold for scrub typhus is ≥1:160; ≥1:320 is highly significant)
• Fever with high TC
• High CRP (130) but relatively low ESR (20) — this pattern (acute phase reactant dissociation) is characteristic of rickettsial infections
• Already on doxycycline (appropriate first-line agent) — Day 5, still spiking

1. Doxycycline resistance / attenuated response — documented especially in Southeast Asia/India (Thailand strains), and increasingly in Indian subcontinent
2. Inadequate dosing — dose should be 200 mg/day (100 mg BD) IV/oral; confirm this
3. Coexisting confounding source of fever — the large pelvic mass/endometrioma/possible TOA is an independent fever driver
4. Severe scrub typhus with organopathy — hepatomegaly supports this; rickettsial vasculitis can cause prolonged fever

Diagnosis 2: Large Pelvic Complex Mass — Endometrioma vs. Malignancy

Further Evaluation Needed

For Rickettsial / Infectious Workup

1. IFA (Indirect Fluorescent Antibody) for Orientia tsutsugamushi — gold standard; Weil-Felix OXK is a screening test only (sensitivity ~50–75%, specificity limited); confirm with IFA serology (paired titres: acute + convalescent 2 weeks apart showing ≥4-fold rise)
2. PCR for Orientia tsutsugamushi from blood / eschar biopsy — most sensitive in first week of illness
3. Eschar search — thorough skin exam (groins, axillae, hairline, perineum); present in 50–80% of scrub typhus cases; finding an eschar is pathognomonic
4. Blood cultures — rule out concurrent bacteremia (the large pelvic mass could have become infected; piperacillin-tazobactam is broad-spectrum and appropriate for that)
5. LFTs + Bilirubin — scrub typhus causes hepatitis; high aminotransferases expected
6. Procalcitonin — helps distinguish bacterial from rickettsial/viral fever if intermediate
7. Dengue serology (NS1, IgM/IgG) — co-infection possible in endemic region, can cause persistent fever
8. Leptospira IgM ELISA / MAT — fever with hepatomegaly in India; important differential
9. Malaria smear + RDT — mandatory in any Indian PUO

For Pelvic Mass

1. MRI Pelvis with contrast — recommended by the radiologist ("SOS MRI correlation"); superior to CECT for characterising ovarian masses, solid components, capsule integrity, peritoneal implants
2. CA 19-9, CEA, HE4, LDH — complete tumour marker panel for ovarian pathology
3. ROMA score (Risk of Ovarian Malignancy Algorithm) using CA-125 + HE4
4. Gynaecology-Oncology consultation — urgent; mass is 18 cm with solid components and nodes; surgical planning required
5. Bone scan or PET-CT — for the vertebral lytic/sclerotic lesions; if malignancy confirmed, this is staging
6. FNAC/biopsy of retroperitoneal node if accessible — tissue diagnosis
7. Endoscopy (colonoscopy) — if rectal abutment symptoms present; CT shows focal rectal contact

Treatment Plan

For Persistent Fever / Rickettsial Disease

• For severe scrub typhus with persistent fever at Day 5:
  • Option A: Add Azithromycin to Doxycycline — combination shown to reduce composite poor outcomes (33% vs 47–48% with monotherapy) in the MORU severe scrub typhus trial
  • Azithromycin: 500 mg IV/oral OD × 3–5 days
  • Azithromycin has superior intracellular penetration; doxycycline acts faster on extracellular bacteria; combination covers both compartments
• Option B: Switch to Azithromycin if doxycycline resistance suspected (especially with Indian/South Asian strains)

• Must be 100 mg BD (200 mg/day) IV or oral — not 100 mg OD

• The large pelvic mass could be infected endometrioma / tubo-ovarian abscess contributing to ongoing fever — piperacillin-tazobactam covers this (continue)
• If mass is infected, surgical drainage may be needed after oncological assessment

Regarding the Mass

• Do NOT rush to surgery while active rickettsial infection is ongoing — risk of complications
• Treat infection first, then proceed with elective/semi-elective gynae-oncology evaluation
• However, if the mass is felt to be an infected TOA causing fever independently, drainage (laparoscopic or IR-guided) may be needed

Summary Table

Key Clinical Pearl

References: Harrison's Principles of Internal Medicine 22e (Chap. 192 Rickettsial Diseases) | Sherris & Ryan's Medical Microbiology 8e | PMID: 38110855 (meta-analysis doxy vs azithromycin scrub typhus) | PMID: 37407239 (combination therapy severe scrub typhus)

Clinical Reappraisal: Dual-Agent Treatment Failure

What This Means

Immediate Action Plan

Step 1 — Urgently Revisit the Diagnosis

• Infected endometrioma / tubo-ovarian abscess (TOA) — fever is from pelvic sepsis, not rickettsial
• Ovarian malignancy with peritoneal involvement — tumour fever (IL-6/IL-1 driven), not antibiotic-responsive
• Ruptured/leaking endometrioma causing chemical peritonitis

Step 2 — Escalate Investigations Now

Step 3 — The Pelvic Mass Needs Urgent Characterisation

• MRI Pelvis with contrast — cannot defer further; critical to determine if this is an infected TOA, endometrioma, or malignancy
• Tumour markers: CA-125 (already done = 150), add HE4, CA 19-9, CEA, LDH, AFP (AFP + LDH for germ cell tumour given her young age — 30yr)
• Gynae-Oncology consultation today
• If TOA is confirmed — surgical drainage (laparoscopic or ultrasound-guided aspiration) is therapeutic and removes the fever source; antibiotics alone often fail TOA >8 cm

Step 4 — If Scrub Typhus Still Suspected Despite Failure

• Rifampicin 600–900 mg/day orally × 7 days
• Evidence from Watt et al. (Lancet 2000) and multiple Indian case series: rifampicin is active against doxycycline-resistant Orientia tsutsugamushi
• Mechanism: RNA polymerase inhibition — different target from tetracyclines/macrolides
• Used successfully in Southeast Asia where doxycycline resistance is documented
• Can be used as monotherapy or combined with doxycycline (doxycycline + rifampicin combination shown active in vitro)

Note: Rifampicin is an enzyme inducer — check drug interactions, and it turns urine/secretions orange (warn patient)

Diagnostic Hierarchy Summary

Persistent fever despite Doxy (100BD) + Azithromycin × 5 days
            |
    ┌───────┴────────┐
    ↓                ↓
Scrub typhus      Fever from pelvic 
still active?     mass (TOA / malignancy)?
    |                ↓
IFA + PCR       MRI pelvis + 
blood cultures   Gynae-Onco consult
    |                ↓
Rifampicin       Drain if TOA
600-900mg/d      Chemo/Surgery if malignancy

The Vertebral Lytic Lesions — Must Not Be Ignored

Practical Bottom Line

1. Stop chasing rickettsial disease blindly — both standard agents have been given for 5 days and failed
2. The pelvic mass is now the leading diagnosis for fever — it needs definitive characterisation urgently
3. Add Rifampicin only if IFA/PCR confirms active rickettsial disease and other sources are excluded
4. Piperacillin-tazobactam should continue — it covers the infected mass/TOA component
5. Urgent MRI pelvis + Gynae-Oncology review today — the clinical picture is evolving towards a malignancy workup, not an extended antibiotic course